Collagen VI myopathies are genetic disorders due to mutations in collagen 6 A1, 2, and 3 genes, ranging from the severe Ullrich congenital muscular dystrophy to the milder Bethlem Myopathy, which is recapitulated by collagen VI null (Col6a1 
Introduction
Collagen VI (ColVI) is a major component of the extracellular matrix (ECM) crucial for muscle cell adhesion, stability and regeneration. COLVI forms a microfibrillar network involved in maintaining tissue integrity through a structural link between different components of connective-tissue basement membranes and cells (Allamand et al., 2011) . COLVI is a heterotrimeric molecule composed of three α-chains encoded by distinct genes (COL6A1, COL6A2, COL6A3).
The three alpha−chains first assemble in equimolar association into a triple helical monomer, and successively form dimers and tetramers stabilized by disulfide bonds. The secreted tetramers
give raise to a network of microfilaments that bridge the sarcolemma with the extracellular connective tissue (Bonaldo et al., 1990) . Mutations occurring in the three ColVI genes cause two major disease phenotypes: a mild form, Bethlem myopathy (BM), and a severe form, Ullrich congenital muscular dystrophy (UCMD) (Gualandi et al., 2012) . Three additional ColVI genes have recently been described, COL6A4, COL6A5 and COL6A6, and code for the α4(VI), α5 (VI) and α6(VI) protein chains, respectively. However, only α6(VI) is highly expressed in skeletal muscle, although not associated with basement membranes (Tagliavini et al., 2014a ) and none of these additional ColVI genes are known as disease genes in humans.
COLVI myopathies are well defined conditions, characterized by a broad spectrum of clinical features, ranging from prenatal onset with decreased fetal movements; hypotonia or torticollis, early-childhood onset -by delayed motor milestones, muscle weakness and contractures; and adult onset (4th-6th decade) -by proximal weakness and Achilles tendon or long finger flexor contractures (De Visser et al., 2004) . Due to the progressive nature of the condition , 75% of patients over age 50 years need assistance for outdoor mobility (Jöbsis et al., 1999) .
The severe phenotype with early onset, UCMD, is characterized by severe muscle weakness, striking hyperlaxity of distal joints, and proximal joint contractures. In contrast to BM, UCMD is marked by an early loss of ambulation and a rapid disease progression leading to early death caused by respiratory failure (Maraldi et al., 2009 ). In addition, two other conditions have been associated with COLVI myopathy: autosomal dominant limb-girdle muscular dystrophy (LGMD), and autosomal recessive myosclerosis myopathy (Merlini et al., 2008; Scacheri et al., 2002) . Recently, the COL12A1 gene was shown to be mutated in patients with a BM-like phenotype (Hicks et al., 2014) .
Despite this broad clinical spectrum, both muscle function and respiratory performance evaluation can address the diagnosis. Nevertheless, UCMD and BM can be inherited accordingly to both dominant and recessive models, and generally, neither the type of mutation (missense, nonsense, splicing insertion or deletion), nor the effect of the mutation on the protein structure/function allows precise discrimination between two phenotypes (Allamand et al., 2011 ; Journal of Cell Science • Advance article may influence the mutated genes expression, therefore impacting on the resulting phenotype.
The Col6a1 -/-mouse is a well studied animal model for COLVI myopathies. These mice carry a targeted inactivation of the α1(VI) chain and exhibit an early onset myopathic phenotype that strongly resembles BM (Bonaldo et al., 1998) . Muscle fibres of Col6a1 -/-mice show loss of contractile strength and a number of structural defects in the hind limb muscle and especially in the diaphragm. Although the pathology associated with collagen VI myopathy is nonspecific and variable, it has been widely documented (Grumati et 
Col6a1
-/-mice and UCMD/BM patients do also show defective autophagy (Grumati et al., 2011 ).
This suggests a mechanism of disease pathogenesis that might be in part due to defective regulation of autophagy, which leads to accumulation of abnormal mitochondria and sarcoplasmic reticulum. Moreover, in Col6a1 -/-mice, changes in metabolic proteins resulting in decreased glycolysis and affecting the tricarboxylic acid (TCA) cycle fluxes lead to a different fate of aketoglutarate triggering lipotoxicity. The metabolic changes are associated with changes of proteins involved in mechanotransduction at the myotendineous junction/costameric/sarcomeric level and in energy metabolism (De Palma et al., 2013) . Recently, a strong depletion of the α6(VI) chain in skeletal muscle has been reported as potential biomarker of COLVI myopathies (Tagliavini et al., 2014a) . In spite of these recent achievements, a full understanding of COLVI disease pathogenic mechanisms remains unknown.
Gene expression profiling and RNA sequencing are powerful tools to explore the transcriptional alterations in disease tissues (Sánchez-Pla et al., 2012). It brought great advances in cancer research and disclosed deregulated transcripts that are now being considered as prognostic/therapeutic biomarkers of neoplastic diseases (Sevov et al., 2012; Campo, 2013) . Considering the availability of novel therapeutic possibilities for rare muscle disorders (Aartsma-Rus and Muntoni, 2013), finding prognostic biomarkers for disease severity or drug response will be of great benefit for patient care and treatment (Ferlini et al., 2013; Scotton et al., 2014 figure 2 . Identified GO groups were broad categories. therefore not specifically addressing any definite biological effects occurring in Col6a1 -/-mice. We also performed GO analysis of 334 genes differentially expressed in the "pooled" data from all three muscle groups compared with "pooled" WT muscles. This GSEA identified the GO groups shown in Figure 1 . One of the top 10 GO groups was "rhythmic process" containing genes regulating circadian rhythms as well as known genes that are regulated downstream of the molecular clock, such as DBP, and all were down-regulated in Col6a1 -/-muscles.
To identify key regulators that change their activity in Col6a1 -/-muscles, we used sub-network enrichment analysis (SNEA) in Pathway Studio. Our first SNEA was done using the list of genes differentially expressed in one direction in all muscle types as an input. Regulators identified by this approach are shown in Figure 2 . Genes changing their expression in one direction in all muscle types are primarily regulated by inflammatory cytokines and their receptors. In good agreement with the GO analysis, SNEA of the "pooled" dataset found ARNTL (gene encoding the molecular clock factor, BMAL1), CLOCK, PER1, and PER3 regulators that belong to cellular circadian rhythm pathway ( Fig. 2 and table S2 ). We then explored the intersection between the two SNEA analyses and found consistent results (Fig. 2 and table S2 ). Indeed, we found CLOCK, ARNTL, GFI1B, IL2, CD28, PIM3 and inflammatory cytokines key regulators upstream of genes differentially expressed in all comparisons. In total 46 key regulators were identified by the three comparisons.
To validate the 46 key regulators selected by SNEA, we studied the differential expression of these transcripts using TaqMan low-density arrays (TLDA). By comparing the microarray experiments data to those of the TLDA cards we observed the same trend of fold change in 37 out of 46 genes (80%) of the diaphragm and TA, whereas in the gastrocnemius we found 32 out of 46 genes (70%) with these features (Figs. S3A, S3B ).
Both in diaphragm and TA and , to a lesser extent in gastrocnemius, the TLDA and microarray data for regulators of the rhythmic process (ARNTL, ATF5, CLOCK, DBP, EGR1, FKBP5, PER1, PER2 and PER3) and transcription factors important for muscle-related processes (MY-OD, MYOG, MYF6, PAX7) were in good agreement. This confirmed the deregulation of these two pathways in the Col6a1 -/-mice (Fig. S3B) .
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Western blot revealed that CLOCK levels were significantly (Student's t-test, n = 3, p-value < 0.05) increased in diaphragm and TA muscles of Col6a1 -/-mice compared with their respective WT controls, whereas they remained unchanged in gastrocnemius. MAT2A protein levels did not change significantly in the diaphragm, whereas in TA and gastrocnemius muscles they were, respectively, increased and decreased (Fig. 3A) . (4) . In addition to COLVI, components of the autophagy pathway were also affected in the muscle of Bmal1 -/-mice with increased LC3 and decreased p62/SQSTM1 levels, whereas Beclin 1 levels were unchanged. We also found increase in the activation status of AMPK, as defined by higher phospho-AMPK/total AMPK, however this was driven in part by a significant decrease in the levels of total AMPK (Fig. 3B ).
Abnormal collagen VI expression in
Circadian genes show deregulation in muscle from UCMD and BM patients.
Gene expression profiles in the 3 patients (1 UCMD and 2 BM) compared to healthy controls by RNAseq identified several altered transcripts grouped into GO categories (Fig.4A ). Consistently deregulated genes in muscles from UCMD/BM patients are reported in Table 1 . In all three patients, we identified 7 consistently upregulated genes belonging to transcription factor, metabolism process and cellular stress response categories. The 24 consistently downregulated genes are involved in signaling, metabolism, immunity and cell adhesion, axon guidance and circadian rhythm including DNA repair GO categories (Fig. 4B ). Consistent with a link to circadian rhythms we found that 8 of the genes listed in Table 1 are known to be circadian in mouse skeletal muscle and/or changed in expression in the Bmal1 -/-mouse.
In order to find GO groups deregulated in different samples, we performed GSEA analysis (pvalue 0.05 cut-off) for each patient separately. The bi-clustering was performed using Jaccardbased distance between GO groups (based on the number of common genes in groups). This method allowed finding common deregulated "patterns" in different patients, even though the Journal of Cell Science • Advance article GSEA method shows different GO groups. We found genes coding for postsynaptic mem- (Fig. 3C) . BM patients do not show any significant deregulation in the analysed circadian genes. Western blot in 4 UCMD and 3 BM patient muscles showed significantly increased CLOCK protein levels (ANOVA + Tukey, n = 3, p-value < 0.05) in UCMD patients only, whereas MAT2A protein levels were increased in BM patients only (Fig. 3D ).
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Discussion
ColVI myopathies have been both clinically and genetically defined, and alterations in the apoptosis and autophagy circuits have been reported. Nevertheless, the link between mutations of COL6A1-COL6A3 genes and the muscle dysfunction seen in ColVI myopathy still remains elusive. We therefore adopted RNA profiling to study muscle from both Col6a1 -/-mice and BM/UCMD patient biopsies, searching for unique transcriptional patterns. The idea was to detect specific signatures that may enhance our understanding of the pathogenesis of ColVI myopathies. In order to strengthen our findings, we also evaluated protein expression of the transcripts that we found to be consistently deregulated in both mouse and patient muscle tissue.
Col6a1 -/-and Bmal1 -/-mice shows connection between ColVI myopathy and circadian genes
To our knowledge this is the first attempt to study Col6a1 (ARNTL, ATF5, CLOCK, DBP, EGR1, FKBP5, PER1, PER2 and PER3 genes) supports the known data demonstrating that physical activity/exercise can regulate circadian gene expression in skeletal muscle (Wolff and Esser, 2012) . In addition, providing a further bridge between protein and RNA data, intersection between the individual muscle groups and the pooled transcription data, to identify key regulators, showed that inflammatory cytokines and their receptors, known to be regulated by PER1-3 genes, are significantly under-expressed. The connection between ColVI and circadian genes is also strongly supported by our protein findings in Bmal1 -/-mice, which exhibit significant changes in the levels of COLVI chains as well as alterations of the autophagy pathway (Fig.3B ). Since our expression analyses were only performed at one time point, our results can only allow us to conclude that molecular clock pathway is disrupted. Further studies are needed to determine whether the clock factors are phase shifted, damped or arrhythmic.
RNA profiling of COLVI patients shows profound deregulation in ECM-mediated structural muscle remodeling and circadian genes
In the 3 ColVI patients (BM, BMs and UCMD) studied, the highly efficient RNAseq analysis Most intriguingly, and in line with the mouse data, our RNAseq analysis also revealed that circadian-related CRY2 and MAT2A genes were profoundly deregulated. CRY2 is a wellestablished negative regulator of the molecular clock mechanism that underlies circadian rhythms, and MAT2A has a link with circadian rhythms through regulation of the enzyme required for melatonin synthesis, and mediates photoneural-circadian regulation of the pineal gland Recently, BMAL1 was found to be involved in myogenic response to muscle damage, orchestrating the regeneration processes in adult skeletal muscle (Chatterjee et al., 2015) Although these studies suggest that circadian circuit plays a critical role in muscle function and regeneration, the mechanism mediating these effects in skeletal muscle-wasting diseases remains to be elucidated.
Our results demonstrate, for the first time, a deregulation of circadian genes in skeletal muscle of COLVI myopathy that may lead to characterizing the involvement of circadian clock in many other muscle-wasting diseases, opening new therapeutical perspectives.
Putative models linking collagen VI myopathies with circadian rhythm deregulation
The new data suggest a pathogenic connection between circadian-rhythm-gene deregulation and collagen-VI-related myopathies. It appears that CLOCK gene deregulation could provide a link between autophagy, mitochondrial abnormalities, and COLVI diseases. In light of the asynchrony recently described as the mechanism driving regeneration failure (Dadgar et al., 2014) , this relationship could be expressed as one of the two following scenarios:
1) Circadian rhythm deregulation is a downstream effect of COLVI deficiency and contributes
to muscle damage pathogenesis (Fig. 6A) . In this hypothesis, the critical player interconnecting COLVI deficiency with circadian rhythm could be the inappropriate persistence of AKT1 activation. Due to the reduced COLVI expression, this would lead not only to the down-regulation of autophagy (Grumati and Bonaldo, 2012) , but also to the activation of HIF1A transcription factor and the consequent downregulation of GSK3-beta kinase. Indeed, muscle regeneration is a finely 2) Circadian rhythm deregulation in COLVI myopathies is an independent event acting as a secondary modifier of disease severity (Fig. 6B) . 
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Material and Methods
Analysis of Col6a1 -/-mice
RNA extraction
For the focus of this work, we used standardized timing of muscle tissue collection from the Total RNA was isolated from three muscles (diaphragm, gastrocnemius and tibialis) of male mice. Mice were wild type (four) and knock out (four) , aging 6 months. TRIzol extraction (Invitrogen), as specified by the manufacturer, was used. RNA from each muscle was quantified with Nanodrop (Thermo scientific) spectrophotometer. Its integrity was evaluated with a 2100 Bioanalyser (Agilent) prior to pooling equal amounts of RNA from muscles of the same kind.
Col6a1
Analysis of whole genome expression microarray data
We used the Whole Mouse Genome gene expression kit including four arrays of 44,000 probes 
Microarray data analysis
Agilent's Feature Extraction Software (v9.5) was used for array image processing. Intensity data with local background adjustment by spatial detrending were log-transformed and quantilenormalized. Synonymous probes from the same gene were averaged. Software selected 28,052
probes for further analysis. To perform multi-way comparisons we utilized limma package (Smyth et al., 2005) . This package fits a separate linear model for each gene and uses moderated t-statistics to estimate differences between arrays. Empirical Bayes analysis is used to improve Journal of Cell Science • Advance article statistical power in small sample sizes. P-values were corrected for multiple testing using the
Benjamini & Hochberg correction (Benjamini and Hochberg, 1995).
To ascribe biological changes in KO vs. WT muscles we used Gene Ontology term enrichment analysis. GO terms enriched with differentially expressed genes were identified using Fisher exact test. We also performed Gene Set Enrichment analysis (GSEA), (Subramanian et al., 2005) using Pathway Studio 9 from Elsevier.
Potential transcription regulators of the observed expression changes were identified using sub- comparison of molecular clock components across patient samples can be made. The muscle fiber composition in these three muscles shows a predominance of fiber type I (Fig. S4) .
Generally, hereditary myopathies, including the collagen VI myopathies, are characterized by the fiber type disproportion with type I fiber hypotrophy and predominance. (Schessl et al. 2008 ).
Total RNA was isolated from skeletal muscle biopsies of three patients with different phenotypes: UCMD, dominant and recessive BM (BMs) and from one healthy control biopsy using the RNeasy-kit (Qiagen, Chatsworth, CA) according to the manufacturer's instructions. We verified high-quality of isolated RNA and RNA integrity using an Agilent Technologies 2100 Bioanalyzer. The isolated RNA had RNA Integrity Number (RIN) value greater than 8.
RNAseq
1 μg of total RNA sample was used for polyA+ mRNA selection using streptavidin-coated magnetic beads, followed by thermal mRNA fragmentation. Fragmented mRNA was retrotranscribed using reverse transcriptase (Super-Script II) and random primers. The cDNA was converted into double stranded cDNA, its ends were repaired using Klenow fragment, T4 polynucleotide kinase and T4 polymerase, and then cDNA was ligated to Illumina paired end (PE) adaptors. Size selection was performed using a 2% agarose gel, generating cDNA libraries rang- We performed mapping of reads to human genome using TopHat software. TopHat, the splice junction mapper for RNA-Seq reads, was run with default parameters. Supplied annotations from hg19 Refseq refGene were downloaded from the UCSC Genome Browser. The mapping results from TopHat were then passed to Cuffdiff, a tool which finds significant changes in transcript expression. In Cuffdiff quartile normalization was turned on, Bias Correction was set on, Min
Alignment Count was set to 10, and all other parameters were set to default. Both TopHat and
Cuffdiff were run on the free pubic Galaxy server (http://galaxyproject.org/). To identify consistently deregulated genes, differential probes were identified by OK test in Cufflinks (Trapnell et al., 2010) . Log-ratios were calculated as difference between patient and control.
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Quantification of CLOCK and MAT2A transcripts by real-time PCR
To validate the deregulated expression of CLOCK and MAT2A genes, we enlarged our patient cohort. We analysed twelve UCMD, nine BM, three patients with intermediate phenotypes and a pool made of muscle controls. All ColVI patients have been clinically characterized with regard to "circadian involvement" -date and time of biopsy, if the patients were fasting or taking drugs, if the patients were ambulatory and the presence of ventilation at the time of biopsy (Table S3) .
Total RNA was isolated from muscle sections using RNeasy Kit (QIAGEN, Chatsworth, CA) and reverse transcribed by using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). In order to quantify the steady state level of CLOCK and MAT2A transcripts, commercially available TaqMan 
Western blotting analysis in Col6a1 -/-mice and ColVI patients
For immunoblotting analysis, frozen muscle tissues from both patients and mice were ground in a dry ice-cooled mortar and stored at -80°C. An aliquot of each frozen muscle was suspended in lysis buffer (urea 7M, thiourea 2M, CHAPS 4%, Tris 30mM, and PMSF 1mM) and solubilized by sonication on ice. Samples were pooled and protein concentrations were determined using PlusOne 2D-Quant kit (GE Healthcare, Milan, Italy). Total protein extracts (50µg) from pooled Manipulations of animals, required for the experiments described, are conform to the rules of the 
